Hypereosinophilia management in patients with type 2 chronic rhinosinusitis treated with dupilumab: preliminary results.

MLA

Vinciguerra, Alessandro, et al. “Hypereosinophilia Management in Patients with Type 2 Chronic Rhinosinusitis Treated with Dupilumab: Preliminary Results.” European Archives of Oto-Rhino-Laryngology : Official Journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : Affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery, vol. 279, no. 11, Nov. 2022, pp. 5231–38. EBSCOhost, https://doi.org/10.1007/s00405-022-07389-5.

APA

Vinciguerra, A., Rampi, A., Yacoub, M.-R., Tresoldi, M., Tanzini, U., Bussi, M., & Trimarchi, M. (2022). Hypereosinophilia management in patients with type 2 chronic rhinosinusitis treated with dupilumab: preliminary results. European Archives of Oto-Rhino-Laryngology : Official Journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : Affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery, 279(11), 5231–5238. https://doi.org/10.1007/s00405-022-07389-5

Chicago

Vinciguerra, Alessandro, Andrea Rampi, Mona-Rita Yacoub, Moreno Tresoldi, Umberto Tanzini, Mario Bussi, and Matteo Trimarchi. 2022. “Hypereosinophilia Management in Patients with Type 2 Chronic Rhinosinusitis Treated with Dupilumab: Preliminary Results.” European Archives of Oto-Rhino-Laryngology : Official Journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : Affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery 279 (11): 5231–38. doi:10.1007/s00405-022-07389-5.